Why Aphria Inc. Ought to Ditch TSX

Aphria Inc. (TSX:APH), one of the best run Canadian cannabis companies, ought to call the TSX’s bluff and move to another exchange. 

Two of my Fool.ca colleagues recently warned that Aphria Inc. (TSX:APH) is playing with fire by holding interests in U.S. cannabis businesses because that potentially puts it offside with both the U.S. Attorney General’s office and the mighty Toronto Stock Exchange.

I have three words for Aphria CEO Vic Neufeld: Call their bluff!

What’s the real risk here?

I believe in assessing stocks based on what I know rather than speculation by others. In recent months there has been a great deal of chatter about the TSX rattling its sword to keep all of its listed companies in line.

The TSX is concerned about Aphria because of its dealings in the U.S. — a nation so hopelessly divided at the moment that the exchange is concerned that Neufeld will be thrown in jail south of the border — taking the good name of the exchange down with him.

I’m being facetious, of course, but in my opinion, the exchange ought to stay out of Aphria’s business for two reasons.

“The U.S. government continues to take a tough stance on marijuana, and Attorney General Jeff Sessions only further complicated things when he stated that federal laws on pot could still be enforced in states where the drug has been legalized,” wrote David Jagielski on January 12. “This legal ambiguity creates a lot of uncertainty for investors, and it’s hard to understand why Aphria would risk running into problems down the road.”

No legitimate business wants to run afoul of the law, especially not a growing cannabis company with a market cap of $3.5 billion.

However, Americans take state rights very seriously.

In a recent poll by HuffPost/YouGov, only 30% of Americans said they would back a move by federal prosecutors to stop the sale and use of marijuana in states where pot is legal. Aphria’s U.S. investments are in Florida and Arizona, where medical marijuana is legal.

Jeff Sessions can do and say whatever he wants, but should the rights of Americans be trampled upon in states where medical and recreational marijuana is legal, you can be sure that there will be years of litigation and court proceedings to protect those rights.

What about the TSX?

As I said earlier, the TSX ought to mind its own business. There’s a difference between believing a listed company is doing something illegal and a lawyer’s opinion that they could be.

However, if the TSX continues to play a game of chicken, I believe that Neufeld ought to take his company’s business elsewhere. There are places to list right here in Canada that would gladly have it — the Canadian Securities Exchange being one; Aequitas Neo Exchange being another. 

The CSE has 53 cannabis issuers listed on its exchange; 17 of them doing business in the U.S. Those 17 companies account for 25% of the CSE’s entire market cap. I’m sure CSE CEO Richard Carlton would have no problem welcoming Aphria into the fold. 

Fool.ca contributor Joey Frenette likens Aphria’s situation to Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) in that Aphria could be forced to sell its U.S. assets quickly at prices that are less than optimal in order to comply with TSX rules and the U.S. Attorney General.

I fail to see how one has anything to do with the other.

Valeant had to unload assets or its bankers would have come calling, hat in hand.

Aphria, on the other hand, has done everything to comply with the laws in the jurisdictions in which they operate. There’s almost zero chance that the company would not be given an opportunity to sell those assets in a way that meets the needs of shareholders.

Chances are, however, it won’t come to that.

Bottom line

The TSX is proving once more why exchanges like the CSE are growing in stature. The TSX’s sabre rattling is both perplexing and counterproductive to building an entrepreneurial, pro-business environment for companies to raise capital in this country.

Take a pass on Aphria stock if you must, but don’t let your decision be guided by conjecture and speculation because at the end of the day, Aphria does have options — good ones, in fact.

Fool contributor Will Ashworth has no position in any stocks mentioned. Tom Gardner owns shares of Valeant Pharmaceuticals. The Motley Fool owns shares of Valeant Pharmaceuticals.

More on Investing

Rocket lift off through the clouds
Tech Stocks

MDA Space Stock: Big Opportunities, but What Should Investors Pay?

MDA’s backlog gives investors work to follow. The share price asks how much of that work will turn into profit…

Read more »

ETF stands for Exchange Traded Fund
Dividend Stocks

Best Canadian Dividend ETF for Passive Income: My Top Pick

Discover why VDY is my top Canadian dividend ETF for passive income, with low fees, tax-efficient dividends, monthly payouts, and…

Read more »

Two seniors walk in the forest
Energy Stocks

A 3.9% Dividend Stock That Will Pay You Through Your Retirement Years

Retirees might buy this dividend stock gradually on market pullbacks, as a part of a diversified retirement portfolio.

Read more »

c
Stocks for Beginners

Canadian National vs. Waste Connections: Which Stock Would I Hold for Steadier Growth?

Waste Connections has the steadier demand story for me. Canadian National offers a lower price relative to earnings and a…

Read more »

tsx today
Stock Market

TSX Today: What to Watch for in Stocks on Friday, November 20

TSX investors will closely watch falling commodity prices today, while escalating U.S.-Iran tensions, Canada-U.S. trade negotiations, and major telecom takeover…

Read more »

how to save money
Energy Stocks

Want $12,000 a Year in Dividends? Here’s the Capital the Goal Requires

A $12,000 dividend target can look more manageable once you see the required balance and how much monthly deposits can…

Read more »

investor looks at volatility chart
Dividend Stocks

2 Discounted TSX Dividend Stocks That Could Rebound in 2027

Two TSX dividend stocks currently trading at deep discounts are well-positioned to stage a strong rebound in 2027.

Read more »

people sit in two wooden beach chairs facing the Caribbean ocean holding drinks and making a toast
Dividend Stocks

How to Build $5,000 in Tax-Free Passive Income in Your TFSA

Building $5,000 in tax-free Income in your TFSA over time is possible with the right portfolio mix and reinvestment of…

Read more »